Thus, IL-4/IL-13/signal transducer and activator of transcription 6 (STAT6) pathway becomes promising targets for asthma therapies by using IL-4 receptor antagonists and anti-IL-13 mAbs [21]. This evidence concerns the gene STAT6 and asthma.